Weight loss medication and expert care with NHS partner Oviva

Oviva’s fully remote consultant-led NHS Tier 3 Weight Management service makes it easy for patients to get holistic, long-term support, and reduces admin and follow-up for GPs.

Refer now

West Yorkshire

These resources are tailored specifically to support referring GPs from West Yorkshire

Understanding the criteria

Learn about the eligibility required for patients to access Oviva’s Tier 3 Weight Management service in West Yorkshire

Kayleigh with medals

Meet Kayleigh

Kayleigh, a patient on Oviva’s Tier 3 Weight Management programme, has achieved life-changing results since joining.

Patient Flyer

Print this flyer for patients who are eligible for Oviva’s Tier 3 Weight Management Programme. We have leaflets in other languages available too.

Our 2 pathways

Eligibility criteria differ between the 6-month diet & lifestyle pathway and the 2-year medically supported programme including GLP-1 medications. Please refer to the toolkit for full eligibility criteria and referral guidance for each pathway.

Oviva App Screens Meal logging

The Oviva app

Learn more about our app and discover how AI is transforming obesity care in our recent free GP webinar.

Meet your Service Engagement Manager, Khalima

Book a short call with me to learn how Oviva can support your patients, including how to identify eligible patients, guidance on the referral process and a quick demo of the app.

Printable Eligibility Poster for your practice

Our West Yorkshire ICB Eligibility Poster helps you quickly identify eligible patients right from your practice room. Download it now to print yourself, or save it to your desktop for easy reference.

Or if you’d rather have it (along with other leaflets and resources) posted straight to your practice, just request printed materials below.

Request Printed Materials            Download Eligibility Poster

How to refer patients in West Yorkshire

1. Run search to identify eligible patients

  • The access criteria for GLP-1 medication in West Yorkshire is the same for Wegovy and Tirzepatide, patients who haven’t been initiated on Tizepatide maybe suitable for Wegovy. Obesity Medication pathway search for Tirzepatide is available on Ardens.

EMIS – Population Reporting or SystmOne – Clinical Reporting

  • Search in folder: Weight Management or Tirzepatide/GLP-1
  • Once located, use Cohort 2- BMI >= 35 (or >= 32.5 if risk ethnicity) + >= 4 qualifying comorbidities.

2. Locate the Referral form

West Yorkshire ICB have Oviva’s T3WM referral form available centrally. Please access via Ardens on EMIS or SystmOne.

3. Submit the Referral form

Once completed, please send the referral form and any relevant attachments using one of the following methods.

  • Email: ovivauk.t3wm@nhs.net
  • NHS e-Referral Service (eRS) Please use the Secondary Care menu and search the following terms on the system:

Name: Tier 3 Weight Management Service (medical) – Oviva

Speciality: Endocrinology & Metabolic Medicine

Clinic type: Not otherwise specified

Organisation or site name: Oviva

Illustration of a healthcare professional raising one hand, with a medical cross on their uniform.

Frequently asked questions

What are the clinical outcomes like?
On our Tier 3 programme at 12 months, patients achieve an average 15% weight loss, with 80% app retention at 6 months, alongside a 45% reduction in sick days and 43% fewer GP visits –  demonstrating the impact of our wrap-around, specialist support. 

Who does your team consist of?
We are consultant-led and have a multidisciplinary team to support our patients. This team includes Consultant endocrinologists, specialist GPs, nurses, dietitians, psychologists, psychology wellbeing practitioners, health psychologists and health coaches.

Will my patient put the weight back on once they have stopped taking the weight loss medications?
Our programme combines medication with tailored diet, exercise, and behavioural guidance to help patients build lasting healthy habits. This wraparound care reduces the risk of weight regain and ensures patients maintain their results beyond treatment.

Can’t find an answer to your question?

Read further FAQs